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Abstract
Bacterial populations produce antibiotic-tolerant persister cells. A number of recent studies point to the involvement of
toxin/antitoxin (TA) modules in persister formation. hipBA is a type II TA module that codes for the HipB antitoxin and the
HipA toxin. HipA is an EF-Tu kinase, which causes protein synthesis inhibition and dormancy upon phosphorylation of its
substrate. Antitoxins are labile proteins that are degraded by one of the cytosolic ATP-dependent proteases. We followed
the rate of HipB degradation in different protease deficient strains and found that HipB was stabilized in a lon
- background.
These findings were confirmed in an in vitro degradation assay, showing that Lon is the main protease responsible for HipB
proteolysis. Moreover, we demonstrated that degradation of HipB is dependent on the presence of an unstructured
carboxy-terminal stretch of HipB that encompasses the last 16 amino acid residues. Further, substitution of the conserved
carboxy-terminal tryptophan of HipB to alanine or even the complete removal of this 16 residue fragment did not alter the
affinity of HipB for hipBA operator DNA or for HipA indicating that the major role of this region of HipB is to control HipB
degradation and hence HipA-mediated persistence.
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Introduction
Bacterial populations stochastically produce a small number of
non-growing persister cells that are tolerant to antibiotics [1–4].
Persisters are phenotypic variants that are genetically identical to
the susceptible cells within a clonal population. Thus, persistence is
a non-heritable, transient trait [5,6]. Previously, we have shown
that the recalcitrance of biofilms is largely due to the presence of
persisters [7,8]. Recent studies by our group link persistence to
chronic infectious disease. In the case of cystic fibrosis patients
infected with Pseudomonas aeruginosa, high persister (hip) mutants are
selected for over the course of infection [4]. Similarly, Candida
albicans hip mutants are selected in patients with oral thrush [9].
These findings indicate that persisters are largely responsible for
failure to eradicate chronic infections [4].
Non-growing persisters make up a small part of the population:
10
26 to 10
24 in exponentially growing cultures and ,10
22 in
stationary phase [3,8]. Selection of Escherichia coli for mutants with
increased persister formation produced a strain with two point
mutations in hipA, G22S and D291A, (hipA7 allele) [10–14]. hipA is
the toxin of the hipBA toxin/antitoxin (TA) pair. The antitoxin
HipB represses the hipBA operon by cooperative binding to four
operator sites [10,11,15] and inactivates the toxin HipA. Ectopic
expression of HipA causes multidrug tolerance [16]. Despite the
strong phenotype of the gain-of-function allele hipA7 and HipA
overexpression, a deletion of hipA did not produce a phenotype
[12,16–19]. Similarly, ectopic expression of two other toxins, RelE
and MazF, also strongly increased tolerance to antibiotics, whereas
a deletion of the toxin gene had no phenotype [20]. This is not
surprising given the considerable redundancy in these mRNA
interferases – E. coli has at least 10 of them. Importantly,
progressive deletion of all ten mRNase loci caused a pronounced
decrease in the persister fraction [21].
One notable exception to the redundancy phenomenon is the
toxin TisB, a membrane-acting peptide that causes dormancy by
decreasing the pmf. Deletion of the type I TA module (small RNA
antitoxin/protein toxin) tisAB led to a pronounced decrease in the
level of persisters. TisB is induced by the SOS response, and
becomes the main mechanism of persister formation during SOS
response, so a deletion has a phenotype [22,23].
Unlike any other toxins of type II TA modules (protein
antitoxin/protein toxin) which so far group mainly into either
gyrase inhibitors (ParD, CcdB), mRNA interferases (RelE, MazF,
YoeB, HicA, Doc) [24–26] or PIN domain fold proteins (VapC)
[22,27], HipA is a kinase with a eukaryotic Ser/Thr kinase-like
fold [16]. Replacing the conserved amino acids in the phosphor-
ylation site (S150A) or the Mg
2+- or catalytic binding sites (D332Q
and D309Q respectively) abolishes the ability to confer growth
arrest and antibiotic tolerance [16]. Elongation factor Tu (EF-Tu)
was identified as a HipA target which points to a likely mechanism
of HipA-mediated persister formation [15]. HipA phosphorylates
EF-Tu, and Thr
382-phosphorylated EF-Tu leads to stasis since it
can no longer bind aminoacyl-tRNA [15]. Under the standard
regime of batch culture growth the persistence function of HipA is
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antitoxin HipB has to be removed or degraded. Proteolytic
regulation of the antitoxin has been demonstrated for several TA
modules. In E. coli, the chromosomally encoded TA modules
MazEF, RelBE, YefM/YoeB, HicAB, DinJ/YafQ and MqsRA
are regulated by the AAA+ ATP-dependent proteases Lon and/or
ClpPX [24,28–30]. ClpPA degrades the PhD antitoxin of the
plasmid-encoded PhD/Doc TA module [22]. The other two ATP-
dependent proteases HslVU and FtsH do not have any known
antitoxin substrates [22,24]. In this study we provide evidence that
Lon is the main protease responsible for HipB degradation. Our
data suggests that Lon recognizes the unstructured C-terminus of
HipB.
Results
Rapid degradation of HipB is dependent on the presence
of Lon
HipB does not share homology with any of the known
antitoxins. Neutralization of its cognate toxin also differs
mechanistically from other TA modules. Typically, the antitoxin
contains an extended C-terminal stretch, which is structured only
when in complex with its toxin [31–36]. Contacts usually involve
residues near the active site of the toxin, which can simply be
blocked by the antitoxin [33,35–37] or make it sterically
impossible for the toxin to reach its target [31,32,34]. HipB,
however, does not make any contacts with HipA near the active
site. One HipB dimer binds two HipA molecules involving
interactions with both the N and the C domain of HipA [15]
(Fig. 1A). The C terminus of HipB is disordered (Fig. 1B) and
remains unstructured in the presence of HipA [15]. To test
whether proteolytic regulation is a shared characteristic of HipB
with the typical antitoxins of the mRNA interferase and gyrase
inhibitor TA modules, despite functional and structural differenc-
es, we measured the rate of in vivo degradation of HipB in wild type
E. coli. Since endogenous HipB could not be detected by Western
Blotting using a polyclonal antibody to HipB (data not shown), N-
terminally six-his tagged HipB (His6-HipB) was expressed from a
plasmid containing an IPTG inducible promoter (pBRhipB). After
60 min of induction, protein synthesis was stopped by the addition
of chloramphenicol and the rate of HipB proteolysis was
determined by Western blotting (Fig. 2A). His6-HipB was
degraded with a t1/2 of <17 min in wild type cells confirming a
rate of degradation characteristic for antitoxins [38,39]. Next, we
transformed pBRhipB into protease deficient strains lacking lon
(KLE902); clpP (KLE903); or hslVU (KLE904) to identify a
protease responsible for HipB degradation. We compared the rate
of in vivo degradation of HipB in wild type to the rate of
degradation in the protease deficient strains. Deletion of clpP or
hslVU had a slight effect on HipB. The half life time of HipB was
approximately 24 min in DclpP and 28 min in DhslVU. Deletion of
lon stabilized HipB (Fig. 2) (t1/2.200 min), indicating that Lon is
likely the main protease involved in HipB degradation in vivo.
Since deletion of Lon protease had the strongest effect on the HipB
turnover, we focused our studies on Lon dependent HipB
degradation.
HipB is a substrate of the ATP-dependent protease Lon
To determine whether HipB is directly recognized and
degraded by Lon we purified His6-Lon and His6-HipB for in vitro
degradation studies. Lon degraded HipB with a t1/2 of <74 min in
vitro confirming our findings obtained in vivo (Fig. 3A). The HipB
decay however was much slower in the in vitro assay than in vivo.A
difference between in vivo and in vitro degradation rate was also
described for the antitoxin RelB which was degraded rapidly
(tK<15 min) in a Lon dependent manner in vivo, whereas the in
vitro half life time was .60 min [38,39]. Substrate degradation by
Lon requires ATP hydrolysis and Mg
2+ [40]. HipB degradation
was indeed dependent on the presence of ATP and MgCl2 in the
reaction buffer demonstrating that degradation of HipB is specific
to the addition of active enzyme to the buffer (Fig. 3B). The half-
life of HipB in the in vitro assay without either MgCl2 or ATP was
250 min and 168 min, respectively. There was some residual
degradation in the absence of either ATP or Mg2+; however, both
factors were clearly required for Lon-dependent degradation of
HipB.
HipB functions as an inhibitor of HipA and as an autoregulator
of the hipBA operon by cooperatively binding to the consensus
sequence TATCCN8GGATA. We tested whether Lon also
degrades HipB when it is bound to DNA or HipA. Addition of
a 21 bp oligo ACTATCCCCTTAAGGGGATAG (sequence of
top strand) spanning the hipBA operator sequence reduced the rate
of degradation (t1/2.200 min) (Fig. 3C), while addition of a
control oligo (sequence of top strand ATGATGAGCTTTCA-
GAAGATC) showed little effect. Similarly, addition of purified
His6-HipA slowed down the rate of HipB proteolysis (t1/
2.200 min) as compared to a control protein (lysozyme)
(Fig. 3D). Thus, HipB appears to be rapidly degraded only when
it is free and not functioning as a transcriptional inhibitor of the
hipBA operon or neutralizing the HipA protein.
The unstructured C-terminus of HipB is critical for
degradation
The HipB dimerization interface is composed of a small
hydrophobic core and the b-lid, a two-stranded intermolecular b
sheet that is followed by an unstructured 16 amino acid C-
terminus (AKNASPESTEQQNLEW) [15]. Proteases typically
bind disordered regions of their substrate, thus the unstructured C
terminus appears to be an excellent recognition site for protease
attack [15]. To test the hypothesis that the 16 residue C-terminal
stretch is critical for degradation, we cloned a truncated HipB
(HipB72) lacking the last 16 residues of HipB into pBR creating
pBRhipB72. We measured the rate of in vivo degradation of
HipB72 in wild type and Dlon (KLE905 and KLE906, respectively)
(Fig. 4). Interestingly, HipB72 is indeed substantially more stabile
(t1/2.200 min) than full length HipB in wild type indicating that
the unstructured C terminus of HipB is essential for degradation
by Lon protease (Fig. 4A). As expected, full length HipB72 is also
stable in Dlon background. We purified the truncated HipB (His6-
HipB72) and tested it in the Lon in vitro degradation assay. The
effect was also noticeable though less pronounced in vitro. The half-
life time of HipB changed from 74 min for full length HipB to
130 min in the mutant (Fig. 4B). To confirm that the unstructured
C terminus of HipB is a degradation signal for Lon protease, we
fused the C terminus of GFP with the unstructured C-terminal tail
of HipB (creating pBRGFP-H, KLE908), and tested whether
addition of the carboxy-terminal stretch of HipB (residues 73–88)
causes degradation of GFP, which by itself is stable over the time
period of the experiment (t1/2.200 min) (Fig. 5). The GFP-HipB
tail hybrid was much less stable with a half-life time of <53 min
confirming that the C-terminus of HipB is critical for rapid
proteolysis of HipB.
The C-terminus of HipB does not affect binding to either
HipA or operator DNA
The possibility that the last sixteen residues of HipB had
additional functions beyond their role in protein stability was
HipB Degradation by Lon Protease
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residue of HipB, W88, which is universally conserved (Fig. 6),
interacted with a small surface pocket of HipA [41]. We first tested
the effect of changing residue 88 to an alanine on HipB-DNA
affinity. Using a fluorescence polarization-based assay and the
hipBA O1O2 operator site, we determined that wild type HipB
bound this sequence with a Kd=0.660.1 nM (Fig. 7A, 1). As
anticipated from the HipA-HipB-DNA crystal structure [15], the
HipB(W88A) protein bound this DNA with wild type HipB affinity
(Kd=0.960.4 nM). Deletion of the last sixteen residues of HipB,
(HipB72) also showed no change in DNA binding affinity
(Kd=0.460.1 nM) (Fig. 7A, Table 1).
To test the hypothesis that W88 or other residues of the C-
terminus contributes to HipA binding, we measured the dissoci-
ation constant of HipA for HipB (Fig. 7B and C). The reporter
molecule in this assay is the hipBA O1O2 sequence, which is
saturated with HipB by using HipB concentrations 50 fold greater
than Kd. HipA binding to HipB will result in a further, saturable
increase in fluorescence polarization from which the HipA-HipB
Kd can be ascertained. The dissociation constant of HipA binding
to HipB was 1 mM under our experimental condition (Fig. 7B and
C, Table 1). The Kd of HipA for HipB(W88A) was identical to the
wild type HipB Kd as was the Kd of HipA for HipB72 (Fig. 7C,
Table 1). Titration of HipA into O1O2 DNA in the absence of
HipB results in linear, nonspecific DNA binding (data not shown).
These results demonstrate that the C-terminus of HipB does not
play a role in binding to either hipBA O1O2 DNA or HipA.
Discussion
The hipBA toxin/antitoxin locus shares several characteristics
with other TA modules, such as the genetic organisation in an
operon with the antitoxin overlapping the toxin by one base pair,
tight regulation of the operon by the antitoxin and inhibition of the
toxin by its antidote. In addition, ectopic expression of the toxin
confers growth arrest, which can be overcome by antitoxin
expression. However, the HipBA TA system does not group into
the three common toxin families of RelBE-, the MazEF- and
VapBC-like members. Toxin and antitoxin are structurally and
mechanistically distinct from all other characterized TA pairs.
HipA is a kinase, and HipB belongs to the Xre-helix-turn-helix
family of transcriptional regulators. Binding of HipA-HipB2-HipA
to DNA introduces a 70u bend in the operator [15]. In contrast to
other antitoxins, HipB interacts with HipA via the N and C
domain and the C terminus of HipB remains unstructured in the
presence of the toxin [15]. Despite functional differences,
regulation by proteolysis is a shared characteristic with all other
protein-coding antitoxins. We find that HipB is a substrate of Lon
protease since HipB is stabilized in the absence of Lon and
Figure 1. Overview of the hipBA locus of E. coli based on Schumacher et al. (A) Model of the hipBA operon. One of four operator sites is
shown. (B) View of the crystal structure of the HipB dimer bound to a 21 base pair hipBA operator site (from reference [15]. One HipB subunit is
colored green and the other red. The a helices are shown as coils and the a strands as arrows. The amino termini of each subunit are labelled N and
the carboxy termini, C. The 16 C-terminal residues (73–88) are unstructured and residues 75–88, which are disordered in the structure of the HipA-
HipB-DNA complex, are depicted as dashes and could easily extend from the body of HipB by more than 50 A ˚.
doi:10.1371/journal.pone.0039185.g001
Figure 2. HipB proteolysis in E. coli wild type and protease
deficient strains. HipB was expressed from pBRhipB in BW25113
(KLE901) and its lon::kan (KLE902), clpP::kan (KLE903) or hslVU::FRT
(KLE904) derivate. The strains were grown in LB medium, and at an
OD600 of 0.3 1 mM IPTG was added. After 1 h induction, protein
synthesis was inhibited by the addition of 100 mg/ml Cam, and samples
for Western blots were removed over the course of 30 min. (A) The
presence of HipB in whole cell lysates was detected with an anti-his
antibody. (B) The rate of degradation was calculated from at least 3
independent experiments. Closed squares, KLE901 (wild type); open
squares, KLE902 (Dlon); closed triangles KLE904 (DhslVU); open
triangles, KLE903 (DclpP).
doi:10.1371/journal.pone.0039185.g002
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neutralizes HipA and represses transcription of the hipBA operon.
However, when no new HipB is produced or Lon activity reaches
elevated levels, HipB turnover results in free HipA. Shutdown of
HipBA synthesis might be further regulated at the transcriptional
or translational level, both diminishing the level of HipB decay and
thus freeing up HipA. Currently, little is known about the activity
of the hipBA promoter under different growth conditions. The
position of an IHF binding site upstream of the hip operon suggests
a level of transcriptional regulation beyond repression by HipB
and HipBA binding to the operator. The activity of Lon protease
is upregulated during stresses [42,43]. Polyphosphate (poly-P)
binds to Lon and promotes degradation of ribosomal proteins (S2,
L9, L13) while degradation of other proteins (e.g. SulA) is inhibited
by poly-P [44,45]. Though a regulator of Lon activity that directs
Lon to act on HipB has not been identified, it is possible that such
a regulator exists. Increased activity of Lon will result in faster
degradation of HipB faster and release free HipA. An additional
possibility for regulating HipBA is that chaperones can potentially
play a role in removing HipB from HipA. Though there is no
direct evidence that a HipB is specifically regulated by chaperones,
the persister level is 10-fold reduced in a dnaK deletion [17]. If a
chaperone sequesters HipB, the persister level will be expected to
be high due to free HipA. Subsequently, deletion of the chaperone
will produce a low persister phenotype.
Irrespective of how it is released, free HipA will in turn
phosphorylate EF-Tu and potentially act on additional targets
leading to the shutdown of essential cellular functions and thus to
dormancy. Phosphorylation of EF-Tu by HipA has been
demonstrated only in vitro and remains to be confirmed in vivo.
Additional targets of HipA are likely, and are currently a subject of
investigation.
Figure 3. Lon degradation of HipB in vitro. 0.6 mM His6-Lon and 0.48 mM His6-HipB were incubated in reaction buffer at 37uC (50 mM Tris-HCl
(pH 8.0), 4 mM ATP, 7.5 mM MgCl2) for indicated times with or without the component specified and subjected to SDS-PAGE and silver staining
followed by analysis (at least 3 independent experiments were used to calculate HipB turn over). (A) In vitro degradation of His6-HipB by His6-Lon. (B)
ATP or MgCl2 were omitted in the assay. Closed squares, no ATP; open squares no MgCl2. (C) Addition of an oligodeoxynucleotide encompassing the
21 bp hip operator (closed squares) or control oligo (open squares) and (D) addition of His6-HipA (closed squares) or control protein (lysoszyme)
(open squares) to the degradation assay.
doi:10.1371/journal.pone.0039185.g003
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ectopically expressed HipA surpasses a certain threshold growth is
arrested, whereas at low HipA levels growth is not affected, which
leads to the formation of a distinct dormant; and growing
subpopulation, correspondigly [46]. Considering our results, by
controlling HipB degradation, Lon protease is the driving factor
shifting HipA above or beyond the threshold levels.
Proteolytic degradation of antitoxins generally plays an impor-
tant role in persister cell formation. Overexpression of Lon
protease caused a 70-fold increase in the level of persister cells
compared to the wild type [21]. The increase in persistence
dropped to a 4-fold difference in a strain lacking all ten mRNA
endonuclease TA systems (D10) in comparison to wild type
control, indicating that Lon-mediated degradation of the antitox-
ins is responsible for the increase in the persister level [21]. Lon
also regulates HipB degradation, and therefore HipBA likely
contributes to the increase in persister formation under conditions
when Lon is produced and HipB is degraded.
Another Lon substrate is the replication inhibitor CspD [47].
Interestingly, overexpression of CspD causes growth arrest [47]
and therefore CspD might also be implicated in persistence.
However, its role appears to be minor. The persister fraction in a
strain overexpressing CspD increased less than 10-fold, and
deletion of cspD caused a 2-fold change [48]. Given the known
variability observed in the level of persisters, a robust persister
phenotype of CspD remains to be established. While HipB
degradation by Lon leads to HipA-mediated growth arrest, the
situation is reversed for CspD. CspD-mediated growth arrest
reversed by Lon, suggesting a possible resuscitation mechanism. It
remains to be established how Lon itself is regulated to control
toxin degradation.
Our data show that a disordered C-terminus of HipB serves as a
degradation signal for the Lon protease. We must note that these
results were obtained with an N-terminal his-tagged HipB. It is
unlikely however that this N-terminal his-tag affected degradation.
The common cause of artifacts in determining degradation of
ectopically expressed (including tagged) proteins stems from
formation of aggregates, which include the overexpressed protein,
chaperones and proteases. This is the case for a number of
membrane-associated proteins, whereas overexpression of soluble
GST-GFP did not result in aggregation [49]. His6-HipB is soluble
and we have no indication that aggregates are formed and are
interfering with degradation of HipB. HipB and CspD both have
in common an extended or disordered C-terminus [47]. While
Langklotz and Narberhaus do not observe any differences in
stability of CspD point mutations of non-polar residues in the C-
terminal region (V73D-A74D) and truncations of the C terminus
(lacking the last five, seven, and eleven residues, respectively), we
find that a HipB mutant lacking the conformationally flexible C
terminus is stabilized suggesting that the C-terminus is a signal
sequence for Lon pointing to a different mechanisms of substrate
recognition for these two proteins. The possibility that the HipB
C-terminus functions beyond acting as a degradation tag has been
raised by Evdokimov and colleagues [41]. In the structures of the
HipB-HipA and HipA-HipB-DNA complexes [15], HipB residue
W88 was found bound in a pocket on the HipA surface
approximately 14 A ˚ from the catalytic pocket. This led Evdokimov
to suggest that this residue might be important for HipA-HipB
interaction as well as potentially acting as an allosteric regulator of
HipA activity [41]. Our binding assays show that residue W88 and
indeed residues 73 through 88 play no role in HipA binding to
HipB as the wild type HipB, HipB(W88A) and HipB72 have
Figure 4. The 16 C-terminal amino acid residues of HipB are
required for degradation. (A) Degradation of HipB72 in vivo. HipB72
was expressed from a pBRlacitac promoter in BW25113 (KLE905) and its
lon::kan derivate (KLE906). Both strains were grown in LB medium, and
at an OD600 of 0.3 1 mM IPTG was added. After 1 h of induction, protein
synthesis was inhibited by the addition of 100 mg/ml Cam, and samples
for Western blots were removed over the course of 30 min. (B)
Degradation of HipB 72 in vitro. His6-HipB72 was purified and added to
the Lon degradation assay. At least 3 independent experiments were
performed to calculate HipB72 turnover.
doi:10.1371/journal.pone.0039185.g004
Figure 5. In vivo degradation of GFP and a GFP-HipB hybrid.
GFP and GFP with C-terminal fusion to the C terminus of HipB were
expressed from a pBRlacitac promoter in BW25113 (KLE907 and KLE908,
respectively). The strains were grown in LB medium, and at an OD600 of
0.3 1 mM IPTG was added. After 1 h of induction, protein synthesis was
inhibited by the addition of 100 mg/ml Cam, and samples for Western
blots were removed over the course of 60 min. Closed squares, GFP;
open squares GFP-H (GFP-HipB(73–88)). The graph represents the
average of five independent experiments.
doi:10.1371/journal.pone.0039185.g005
HipB Degradation by Lon Protease
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would also seem to eliminate the possibility that HipB residue W88
regulates HipA allosterically. However, HipA binding to HipB
does appear to block access of Lon to HipB (Fig. 3D). This is not
surprising as the (HipA)2-HipB dimer structure shows that the C-
terminus of HipB is partially shielded from the solvent, which
would hinder its access by Lon [15,41]. Thus, we can conclude
that the last sixteen residues of HipB serve as a highly efficient tag
for the destruction of the antitoxin HipB by Lon protease but only
after its dissociation from the HipA toxin and the hipBA operator.
This requirement for two dissociation events before HipB
degradation might serve to ensure that the switch to persistence
is not thrown accidently.
Materials and Methods
Bacterial strains and growth conditions
The bacterial strains and plasmids used in this study and their
relevant characteristics are listed in Table 2. Strains were grown in
LB medium unless otherwise noted. When required, LB broth or
LB agar were supplemented with ampicillin (100 mg/ml, Amp)
and chloramphenicol (30 mg/ml, Cam).
Plasmid constructions
Primers P1hishipBXbaI (CGGTCTAGATAAGGAGATA-
TATGG AATAATGCACCACCACCACCACCACAT-
GAGCTTTCAGAAGATCTA) and P2hipBEcoRI
(CCGGAATTCTTACCACTCCAGATTTTGCTG) or P2hipB-
sEcoRI (CCGG AATTCGTCGCATAGCGTCATTGAGAG)
were used to amplify hipB from E. coli MG1655; P1GFPXbaI
(CGGTCTAGATAAGGAGATATATGGAATAATGAG-
TAAAGGAGAAGAACT) and P2GFPEcoRI (CCGGAATTCT-
Figure 6. Multiple sequence alignment of selected HipB proteins from a variety of Gram-negative bacteria. CLUSTALW and CLC Main
Workbench were used for the alignment and graphic representation, respectively. HipB sequences were downloaded from NCBI database.
doi:10.1371/journal.pone.0039185.g006
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GAGGCATTTTTCGCTTTGTATAGTTCATCCATGC) or
P2GHEcoRI (CC GGAATTCTTATTTGTATAGTTCATC-
CATGC) were used to amplify GFP from pUA66. The PCR
products were digested with XbaI and EcoRI and ligated into XbaI
and EcoRI sites of pBRlacitac creating pBRhipB or pBRhipB72 and
pBRGFP or pBRGFP-H, respectively.
Mutant generation
The HipB(W88A) mutant and the truncation mutant HipB72
(deletion of all amino acid residues after position 72) were
generated using site directed mutagenesis. Primers used for the
mutagenesis are as follows:
59- AACCTGGAAGCGTAACTCGAGGATCCG and
59- CGGATCCTCGAGTTACGCTTCCAGGTT for
HipB(W88),
59-GGACCGCATATGAGTTTTCAGAAAATCTA-
TAGTCC and
Figure 7. HipB, HipB(W88A) and HipB72 bind hipBA operator DNA or HipA identically. (A) Wild type HipB protein (red closed circle),
HipB(W88A) protein (blue closed square) or the HipB72 C-terminal truncation protein (green closed triangle) was titrated into fluoresceinated hipBA
O1O2 operator sequence and the change in fluorescence polarization (normalized millipolarization, mP) plotted as a function of the concentration of
the titrant. The typical change in mP of each titration was between 60 and 80 units. The correlation coefficients for each curve fitting were 0.98, 0.99
and 0.99, respectively. (B) Wild type HipA protein was titrated into hipBA O1O2 DNA after the DNA was prebound by 20 nM wild type HipB monomer.
Note that the concentration range is different in the left half and right half of the binding isotherms, with HipB titrations in the nanomolar range and
HipA titrations in the micromolar range. (C) Wild type HipA protein was titrated into solutions containing 1 nM fluorescently labelled hipBA O1O2 DNA
and titrated up to 50 nM wild type HipB monomer, 50 nM HipB(W88A) protein or HipB72 protein. This ensures stoichiometric binding of these HipB
proteins to the DNA. Thus, the resulting binding affinity is formally between HipA and HipB that is bound specifically to hipBA DNA. The change in mP
of each titration was between 88 and 150 units. The correlation coefficients for each curve fitting were 0.95, 0.99 and 0.99, respectively. A
representative binding isotherm is shown for each protein binding to DNA or to the HipB-hipBA O1O2 complex.
doi:10.1371/journal.pone.0039185.g007
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for HipB72). The generation of mutants was verified by DNA
sequencing.
Strain construction
Precise deletion-replacement of hslVU was created by the
method of Datsenko and Wanner [50].
Protein expression and purification
N-terminally hexa-histidine (his6)-tagged HipB, HipB72, HipA
and Lon were purified using strains and plasmids indicated in
Table 2. Strains were induced by addition of 0.2% arabinose or
1 mM IPTG for 4 h. Cells were lysed by sonication in the
presence of 1 mgNml
21 lysozyme. Protein extracts were applied to
a Ni-NTA resin (QIAGEN). The columns were washed with
Table 1. Dissociation constants of HipB-DNA and HipA-(HipB-
DNA)*.
O1O2 DNA (nM) HipA (mM)
HipB WT 0.660.1 1.060.6
HipB(W88A) 0.960.4 1.260.3
HipB72 0.460.1 60.1
*The binding constants are the average of at least three separate
measurements.
doi:10.1371/journal.pone.0039185.t001
Table 2. Strains and plasmids used in this study.
Strain or plasmid Relevant characteristics Source or reference
E. coli K-12 strains
MG1655 F
2l
2 ilvG rfb-50 rph-1 [53]
BW25113 lacI
q rrnB3 lacZ4787 hsdR514 D(araBAD)567 D(rhaBAD)568 rph-1 [54]
BW25113 Dlon Dlon::kan Keio collection, [55]
BW25113 DclpP DclpP::kan Keio collection, [55]
BW25113 DhslVU DhslVU::FRT This study
KLE901 BW25113 pBRhipB This study
KLE902 BW25113 Dlon pBRhipB This study
KLE903 BW25113 DclpP::kan pBRhipB This study
KLE904 BW25113 DhslVU::FRT pBRhipB This study
KLE905 BW25113 pBRhipB72 This study
KLE906 BW25113 Dlon pBRhipB72 This study
KLE907 BW25113 pBRGFP This study
KLE908 BW25113 pBRGFP-H This study
KLE319 MG1655 DhipA pBADhipA [16]
AG1 pCA24Nlon AG1 (endA1 recA1 gyrA96 thi-1 relA1 glnV44 hsdR17(rK
2 mK
+)
pCA24Nlon, GFP free
ASKA library, [56]
KLE909 BL21(DE3)pLysS pEThipA [41]
KLE910 BL21(DE3)pLysS pEThipB [15]
KLE911 BL21(DE3)pLysS pEThipB(W88A) This study
KLE912 BL21(DE3)pLysS pEThipB72 This study
Plasmids
pBRlacitac bla lacI
q Ptac pBR322 ori [57]
pBAD33 cat araC PBAD pACYC184 ori [58]
pUA66 pSC101 ori, GFP reporter plasmid carrying GFPmut2, Km
R [59]
pCA24Nlon pCA24Nlon, GFP free, Cm
R ASKA library, [56]
pBRhipB pBRlacitac-hipB This study
pBRhipB72 pBRlacitac-hipB72 This study
pBRGFP pBRlacitac-GFP This study
pBRGFP-H pBRlacitac-GFPhipB(73–88) This study
pBADhipA pBAD33-hipA [16]
pEThipA pET28a-hipA [41]
pEThipB pET15b-hipB [15]
pEThipB(W88A) pET15b-hipB w88a This study
pEThipB72 pET15b-hipB72 This study
doi:10.1371/journal.pone.0039185.t002
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containing 250 mM imidazole. The eluted protein was concen-
trated and dialyzed with protein storage buffer (50 mM Tris-HCl,
pH 8, 250 mM NaCl, 5 mM dithiothreitol [DTT], 5% glycerol)
[51].
Proteins used for fluorescence polarization-based binding assays
were expressed and purified as described below. Plasmid DNA
(pET28a-HipA or pET15b-HipB) was transformed into
BL21(DE3)pLysS competent cells, which were plated onto LB
agar containing 50 mgNmL
21 kanamycin for HipA expressing cells
and 100 mgNmL
1 ampicillin for HipB expressing cells, respectively.
All cells were allowed to grow at 37uC with appropriate antibiotics.
A single colony was selected from each plate and inoculated into
250 mL LB for overnight growth. 40 mL cells were transferred
into 1.5 L LB and were incubated until the OD600 reached 0.6.
Proteins were induced for four hours by adding 1 mM IPTG.
Cells were harvested by centrifugation at 4,0006 g, 4uC for
10 minutes and the harvested cells were stored in 280uC. The
frozen cells were thawed and resuspended in 50 mL buffer A
(20 mM Tris-HCl pH 7.5, 300 mM NaCl, 5% glycerol) contain-
ing one protease inhibitor tablet and 20 mgNmL
21 DNase I
(Roche). After homogenizing the cells with a dounce tissue grinder,
cells were disrupted using a microfluidizer (model M110L,
Microfluidics) and centrifuged at 31,0006 g, 4uC for 1 hour.
The supernatant was applied to 3 mL Ni-NTA affinity resin
equilibrated with Buffer A and allowed to run by gravity. The
column was washed overnight with buffer A containing 20 mM
imidazole at 0.5 mLNmin
21 flow rate. Proteins were eluted with
50–200 mM imidazole gradient. Protein homogeneity was esti-
mated by a SDS-PAGE gel with coomassie staining. Buffer
exchange and protein concentration were achieved using Amicon
ultra centrifugal filter (Millipore). Protein concentrations were
determined by Bradford using BSA as the standard.
Fluorescence polarization-based binding affinity assays
Fluorescence polarization experiments were performed to
determine the binding affinities of HipB, the HipB(W88A) mutant
and HipB72 proteins for DNA and HipA [52]. A DNA
oligodeoxynucleotide containing two hipB operator sites (O1O2)
with the sequence
(59-TTATCCGCTTAAGGGGATATTATAAGTTT-
TATCCTTTAGTGAGGATAA-39) and labeled with 6-carboxy-
fluorescein at 59-end was purchased (Integrated DNA Technolo-
gies Inc) and used without further purification. The labeled DNA
was heated to 95uC for two to five minutes in the presence of an
equal amount of the unlabelled complementary strand. The
strands were annealed by cooling slowly at room temperature.
DNA binding was carried out in 0.5 mL binding buffer A (20 mM
Tris-HCl pH 7.5, 100 mM NaCl and 5% glycerol) in which
1.0 nM labeled DNA was included. Changes in fluorescence
polarization were monitored using a Panvera Beacon 2000
(Panvera Corporation) as a function of increasing concentration
of HipB. Binding was done at 10uC. The binding affinity of HipA
for HipB was determined by titrating HipA into a solution of
50 nM HipB, which was pre-incubated with 1 nM labeled DNA
for 2 minutes, in 0.5 mL binding buffer A. The concentration of
HipB assured the stoichiometric binding of the O1O2 DNA site, as
50 nM HipB is nearly 100 fold more than the Kd that was
determined for HipB-O1O2 binding. The wavelengths used for
excitation and emission were 490 nm and 530 nm, respectively.
Dissociation constants were obtained as described previously [52].
Briefly, the increase in fluorescence millipolarization
(mP=P?10
23, where P is polarization) as a function of the
increasing HipB or HipA concentration is fit using the curve fitting
function of Kaleidagraph and the equation: P={(Pbound2Pfree)
[HipB-DNA]/(Kd+[HipB-DNA])}+Pfree, where P is the polariza-
tion measured at a given concentration of HipB, Pfree is the initial
polarization of the free DNA, and Pbound is the maximum
polarization of specifically bound DNA. For determination of the
HipA affinity for HipB, the same equation is used but the HipB-
DNA term is replaced by HipA-(HipB-DNA). Nonlinear least
squares analysis is used to determine Pbound and Kd.
In vivo degradation and Western Blot analysis
The rate of degradation of HipB, HipB72, GFP and GFP-H
was determined using samples from exponentially growing cells.
Expression of proteins from pBRlacitac was induced by addition of
1 mM IPTG at OD600 of 0.3. After 1 h induction, protein
synthesis was inhibited by the addition of 100 mg/ml Cam, and
samples were removed at indicated time points. Same sample
volume was loaded in each well of an SDS-PAGE gel. Protein
levels were detected by Western blotting using either a monoclonal
His-tag antibody (EMD Biosciences) or polyclonal antibody to
GFP (Abcam) and a polyclonal goat-anti mouse IgG AP conjugate.
In vitro degradation assay
To monitor degradation of HipB, His6-Lon (0.6 mM) and His6-
HipB (0.48 mM) or His6-HipB72 (0.48 mM) were added to a
degradation buffer [50 mM Tris-HCl (pH 8.0), 4 mM ATP,
7.5 mM MgCl2] and incubated at 37 uC. When indicated, His6-
HipB was mixed with either His6-HipA (0.48 mM) lysozyme
(0.48 mM) or duplex DNA containing a 21 bp hipB operator site
(0.24 mM) (sequence of the top strand ACTATCCCCT-
TAAGGGGATAG) or a control deoxynucleotide (sequence of
the top strand ATGATGAGCTTTCAGAAGATC). Samples
were removed at indicated times, and analyzed by SDS-PAGE.
The same sample volume was loaded in each well.
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